SCHEMBL2385102

SCHEMBL2385102

CC(O)c1cc(-c2cc(Cl)ccn2)cs1

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4C Q9H3R0 2/20 0.37
PIM1 P11309 1/20 0.36
MAP4K4 O95819 1/20 0.34
ALDH1A1 P00352 1/20 0.33
MAPT P10636 1/20 0.33
L3MBTL1 Q9Y468 1/20 0.33
HSD17B1 P14061 2/20 0.32
HSD17B2 P37059 2/20 0.32
PTGS1 P23219 1/20 0.32
PTGS2 P35354 1/20 0.32
CYP19A1 P11511 1/20 0.31
ROS1 P08922 1/20 0.31
USP7 Q93009 1/20 0.31
TGFBR1 P36897 1/20 0.31
ROCK2 O75116 1/20 0.31
ROCK1 Q13464 1/20 0.31
SREBF2 Q12772 1/20 0.30
NPC1 O15118 1/20 0.30
RAB9A P51151 1/20 0.30
AAK1 Q2M2I8 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2382655 0.74 PIM1 (0.38) PIM1MAP4K4MAPTHSD17B1HSD17B2
SCHEMBL2382865 0.73 PIM1 (0.36) KDM4CPIM1MAP4K4ALDH1A1MAPT
SCHEMBL2385156 0.73 ALAD (0.42) KDM4CPIM1MAP4K4ALDH1A1MAPT
SCHEMBL2384472 0.71 PIM1 (0.38) PIM1MAP4K4ALDH1A1MAPTL3MBTL1
SCHEMBL26244764 0.71 ALDH1A1 (0.38) ALDH1A1MAPTTGFBR1NPC1RAB9A
SCHEMBL26245691 0.67 ALDH1A1 (0.38) ALDH1A1MAPTCYP19A1SREBF2NPC1
SCHEMBL827247 0.67 CCR1 (0.48) PIM1ALDH1A1MAPTL3MBTL1PTGS1
SCHEMBL31059613 0.67 KDM4C (0.42) KDM4CALDH1A1MAPTL3MBTL1
SCHEMBL31059829 0.67 KDM4C (0.42) KDM4CALDH1A1MAPTL3MBTL1
SCHEMBL31059631 0.67 KDM4C (0.42) KDM4CALDH1A1MAPTL3MBTL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8022209-B2 Substituted nitrogen-containing heteroaryl derivatives useful as modulators of the histamine H4 receptor JANSSEN PHARMACEUTICA NV (BE) 2011-09-20 US disclosed
WO-2009035671-A1 SUBSTITUTED NITROGEN-CONTAINING HETEROARYL DERIVATIVES USEFUL AS MODULATORS OF THE HISTAMINE H4 RECEPTOR JANSSEN PHARMACEUTICA N.V. (BE) 2009-03-19 WO disclosed
US-20090069305-A1 Substituted nitrogen-containing heteroaryl derivatives useful as modulators of the histamine H4 receptor JANSSEN PHARMACEUTICA N.V. (BE) 2009-03-12 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090069305-A1 Substituted nitrogen-containing heteroaryl derivatives useful as modulators of the histamine H4 receptor HRH4, HRH3, HRH2 KDM4C 1258/4885PIM1 4865/4885MAP4K4 2457/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.